Diagnosis, featured, Innovation, Memory, Prevention

When One Door Closes

What the Failure of Biogen’s Aducanumab Tells Us About Alzheimer’s — Risk Reduction is Still Our Best Weapon Today I serve as Neurotrack’s Head Writer. But three years ago, in a different professional incarnation, I had the privilege of sitting in a packed conference room with a bright, articulate representative from the pharmaceutical company Biogen […]

Read more
Uncategorized

Neurotrack Digital Therapeutics Study Finds Certain Lifestyle Changes Can Improve Cognitive Function in Older Adults At Risk for Dementia

(PRESS RELEASE) Neurotrack, an innovative digital health company on a mission to transform the assessment and prevention of memory loss and related diseases like Alzheimer’s, today announced the results of a preliminary study of its forthcoming digital therapeutic program. Designed to slow and/or prevent memory loss among at risk adults, initial findings show improved cognitive […]

Read more